跳至主要内容
临床试验/CTIS2022-501133-23-00
CTIS2022-501133-23-00招募中1 期

Migraine and High Flow Oxygenotherapy at the Emergency Department (MiOx)

Centre Hospitalier Universitaire De Nice0 个研究点目标入组 70 人开始时间: 2022年9月19日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Patients 18 years of age or older, Admitted to the emergency department for migraine-evocative headache according to the criteria of the International Classification of Headaches 3rd edition ICHD-3, Written consent to participate after being informed of the study, Pain intensity at least equal to 6 assessed by the patient’s verbal pain self-assessment

排除标准

  • Patients with risk of respiratory failure by hypercapnia (COPD, cystic fibrosis, morbid obesity, malformation of the chest wall, neuromuscular disorder), Patients under legal protection, Patients treated with triptan in the last 2 weeks, Patients who consumed NSAIDs in the hour prior to physician review, Disabling migraine crisis during for more than 72 hours, History of paraquat poisoning, History of treatment with amiodarone, bleomycin or nitrofurantoin

研究者

相似试验

Migraine and High Flow Oxygenotherapy at the... | 临床试验